Literature DB >> 25416447

MiR-135b promotes proliferation and invasion of osteosarcoma cells via targeting FOXO1.

Hong Pei1, Zhiliang Jin, Shunguang Chen, Xianglun Sun, Jie Yu, Weichun Guo.   

Abstract

Recent data strongly suggest the important role of miRNAs in various cancer-related processes. Osteosarcoma (OS) is the most common primary cancer of the bone and usually leads to deaths due to its rapid proliferation and metastasis. Here, we demonstrated that compared with noncancerous bone tissues, miR-135b expression is frequently upregulated in OS specimens, inversely correlated with potential target-FOXO1 expression pattern. Bioinformatics analysis combined with experimental confirmation revealed FOXO1 is a direct target of miR-135b in OS. Functionally, miR-135b inhibitor significantly inhibited OS cells proliferation and invasion. Forced expression of FOXO1 showed the opposite effect, and FOXO1 knockdown abolished the effect of miR-135b inhibitor. Taken together, our data provide compelling evidence that miR-135b functions as an onco-miRNA in OS to promote OS cells proliferation and invasion, and its oncogenic effects are mediated chiefly through targeting FOXO1.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25416447     DOI: 10.1007/s11010-014-2281-2

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  27 in total

1.  Upregulation of microRNA-107 induces proliferation in human gastric cancer cells by targeting the transcription factor FOXO1.

Authors:  Fan Li; Baohua Liu; Yu Gao; Yuliang Liu; Yu Xu; Weidong Tong; Anping Zhang
Journal:  FEBS Lett       Date:  2013-12-25       Impact factor: 4.124

Review 2.  FOXO transcription factors at the interface between longevity and tumor suppression.

Authors:  Eric L Greer; Anne Brunet
Journal:  Oncogene       Date:  2005-11-14       Impact factor: 9.867

3.  miR-135b coordinates progression of ErbB2-driven mammary carcinomas through suppression of MID1 and MTCH2.

Authors:  Maddalena Arigoni; Giuseppina Barutello; Federica Riccardo; Elisabetta Ercole; Daniela Cantarella; Francesca Orso; Laura Conti; Stefania Lanzardo; Daniela Taverna; Irene Merighi; Raffaele A Calogero; Federica Cavallo; Elena Quaglino
Journal:  Am J Pathol       Date:  2013-04-23       Impact factor: 4.307

Review 4.  MicroRNAs in cancer.

Authors:  Gianpiero Di Leva; Michela Garofalo; Carlo M Croce
Journal:  Annu Rev Pathol       Date:  2013-09-25       Impact factor: 23.472

5.  FOXO1A is a candidate for the 13q14 tumor suppressor gene inhibiting androgen receptor signaling in prostate cancer.

Authors:  Xue-Yuan Dong; Ceshi Chen; Xiaodong Sun; Peng Guo; Robert L Vessella; Ruo-Xiang Wang; Leland W K Chung; Wei Zhou; Jin-Tang Dong
Journal:  Cancer Res       Date:  2006-07-15       Impact factor: 12.701

Review 6.  Causes and consequences of microRNA dysregulation in cancer.

Authors:  Carlo M Croce
Journal:  Nat Rev Genet       Date:  2009-10       Impact factor: 53.242

7.  Liver X receptor α inhibits osteosarcoma cell proliferation through up-regulation of FoxO1.

Authors:  Yue-wen Chang; Yong-fang Zhao; Yue-long Cao; Xin-feng Gu; Zhi-qiang Li; Shu-qiang Wang; Jin-hao Miao; Hong-sheng Zhan
Journal:  Cell Physiol Biochem       Date:  2013-07-12

Review 8.  New molecular insights into osteosarcoma targeted therapy.

Authors:  Jilong Yang; Wei Zhang
Journal:  Curr Opin Oncol       Date:  2013-07       Impact factor: 3.645

9.  MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1.

Authors:  Y Xu; F Zhao; Z Wang; Y Song; Y Luo; X Zhang; L Jiang; Z Sun; Z Miao; H Xu
Journal:  Oncogene       Date:  2011-08-08       Impact factor: 9.867

10.  The antiapoptotic function of miR-96 in prostate cancer by inhibition of FOXO1.

Authors:  Annika Fendler; Monika Jung; Carsten Stephan; Andreas Erbersdobler; Klaus Jung; George M Yousef
Journal:  PLoS One       Date:  2013-11-19       Impact factor: 3.240

View more
  35 in total

Review 1.  Role of Forkhead Box Class O proteins in cancer progression and metastasis.

Authors:  Chang Geun Kim; Hyemin Lee; Nehal Gupta; Sharavan Ramachandran; Itishree Kaushik; Sangeeta Srivastava; Sung-Hoon Kim; Sanjay K Srivastava
Journal:  Semin Cancer Biol       Date:  2017-08-01       Impact factor: 15.707

2.  miRNA-449a is downregulated in osteosarcoma and promotes cell apoptosis by targeting BCL2.

Authors:  Jie Chen; Jinsong Zhou; Xin Chen; Baohui Yang; Dong Wang; Pinglin Yang; Xijing He; Haopeng Li
Journal:  Tumour Biol       Date:  2015-05-23

Review 3.  Posttranscriptional regulation of FOXO expression: microRNAs and beyond.

Authors:  P Urbánek; L-O Klotz
Journal:  Br J Pharmacol       Date:  2016-05-02       Impact factor: 8.739

4.  Gastric bypass surgery with exercise alters plasma microRNAs that predict improvements in cardiometabolic risk.

Authors:  Y O Nunez Lopez; P M Coen; B H Goodpaster; A A Seyhan
Journal:  Int J Obes (Lond)       Date:  2017-03-27       Impact factor: 5.095

Review 5.  Review of microRNA in osteosarcoma and chondrosarcoma.

Authors:  Le Chang; Swati Shrestha; Greg LaChaud; Michelle A Scott; Aaron W James
Journal:  Med Oncol       Date:  2015-04-26       Impact factor: 3.064

6.  MicroRNA-135b regulates apoptosis and chemoresistance in colorectal cancer by targeting large tumor suppressor kinase 2.

Authors:  Yuqi He; Jianxun Wang; Jiheng Wang; Victoria Yee-Wa Yung; Emily Hsu; Aiqin Li; Qian Kang; Junbiao Ma; Qingfeng Han; Peng Jin; Rui Xing; Youyong Lu; Jianqiu Sheng
Journal:  Am J Cancer Res       Date:  2015-03-15       Impact factor: 6.166

Review 7.  FOXO transcription factors in cancer development and therapy.

Authors:  Alexandra Coomans de Brachène; Jean-Baptiste Demoulin
Journal:  Cell Mol Life Sci       Date:  2015-12-19       Impact factor: 9.261

8.  Down-regulation of microRNA-135b inhibited growth of cervical cancer cells by targeting FOXO1.

Authors:  Yue Xu; Shuhua Zhao; Manhua Cui; Qiang Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

9.  MicroRNA-411 promoted the osteosarcoma progression by suppressing MTSS1 expression.

Authors:  Ning Xu; Weiliang Yang; Yang Liu; Feng Yan; Zhange Yu
Journal:  Environ Sci Pollut Res Int       Date:  2018-02-16       Impact factor: 4.223

10.  Downregulation of lncRNA CASC2 facilitates osteosarcoma growth and invasion through miR-181a.

Authors:  Zhiwen Ba; Lili Gu; Songnan Hao; Xiaofang Wang; Zhenping Cheng; Guangchen Nie
Journal:  Cell Prolif       Date:  2017-11-30       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.